Image Credit: Ani Kolleshi

The New Treatment Grant funds advanced, innovative research projects in Australia aimed at accelerating the clinical development of new pancreatic cancer treatments, supporting the translation of promising therapies, scaling existing work, and contributing to the goal of tripling survival by 2030.

This Grant will provide funding for Australian researchers to:

• Carry out developed projects that will significantly accelerate treatments to a clinical stage for pancreatic cancer patients

• Contribute to advancing the translation of research from the lab to clinical studies or practices, accelerating the translation of promising therapies to clinical application

• Contribute to innovative projects that require resources to advance critical milestones

• Extend previous or existing work for a new treatment, scaling up existing research

• Grow capacity in pancreatic cancer in line with our mission to triple survival by 2030

Funding Criteria:

• Projects which are well developed, part of a larger program of work may be suited to this scheme

• Pilot or preliminary data should be developed and detailed as relevant to the application

• Where applications have multiple AI’s, the role of each co-investigator must be outlined and justified

• Only one application per institution may be submitted for each scheme

• International collaborations are encouraged in the PI is located in Australia